FAQs

Zevra was previously known as KemPharm and was founded in 2006. In February 2023, the name was changed from KemPharm to Zevra Therapeutics.

The company is incorporated in Delaware.

Zevra has been public since 2015.

The Company’s stock is listed on the Nasdaq Stock Market LLC (Nasdaq Global Select) under the ticker symbol “ZVRA”.

Computershare

Computershare
www.computershare.com

By Regular Mail:
PO Box 43006
Providence, RI 02940-3006
UNITED STATES

By Overnight Delivery:
150 Royall Street
Suite 101
Canton, MA 02021
UNITED STATES
Telephone
Toll: +1-(781)-575-3100
Toll Free: 877-373-6374

To change the address on your shareholder account you must send both your new and old address to our transfer agent, Computershare.

By Regular Mail:
PO Box 43006
Providence, RI 02940-3006
UNITED STATES

By Overnight Delivery:
150 Royall Street
Suite 101
Canton, MA 02021
UNITED STATES
Telephone
Toll: +1-(781)-575-3100
Toll Free: 877-373-6374
www.computershare.com

Ernst & Young LLP

CUSIP number 488445107.

You may purchase Zevra stock through a registered stockbroker.

Zevra files periodic reports, including Annual Reports (Form 10-K), Quarterly Reports (Form 10-Q) and Current Reports (Form 8-K) with the Securities and Exchange Commission (SEC). These reports are available on our SEC Filings page, or at www.sec.gov.